Burrill Backs Tawian Liposome

Tawian Liposome Co., a developer of drug development technology based on a lipid formulation platform, has raised an undisclosed amount of funding from Burrill & Co. The company has offices in Tapei and South San Francisco.

8 July 2009•3 mins read
Feature image
LinkedInXEmail
LinkedInXEmail